Interestingly, germline ANKRD26 HM phenocopies RUNX1 FPD-MM, with pathogenic variants in ANKRD26 occurring in the 5’UTR and disrupting RUNX1 and FLI1 TF binding sites providing a link to altered TF biology and CHIP. Here, ANKRD26 is linked to Miyoshi myopathy.